US Patent Issued to Proviva Pharma on Sept. 23 for "Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,919, issued on Sept. 23, was assigned to Proviva Pharma Inc. (Montreal).

"Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration" was invented by Susan Westfall (Montreal) and Satya Prakash (Montreal).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a product comprising three bacterial strains that are Lactobacillus fermentum NCIMB 5221, Lactobacillus plantarum NCIMB 8826 and Bifidobacteria longum spp. infantis NCIMB 7022SS."

The patent was filed on Jan. 14, 2024, under Application No. 18/412,561.

*For further information, including images, charts and tables, ...